SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 109 filers reported holding SEELOS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $55,792 | -90.0% | 303,215 | -35.0% | 0.00% | – |
| Q2 2023 | $557,748 | +129008.3% | 466,735 | -25.3% | 0.00% | – |
| Q1 2023 | $432 | -15.0% | 624,862 | -16.5% | 0.00% | – |
| Q4 2022 | $508 | -99.9% | 747,985 | -18.6% | 0.00% | -100.0% |
| Q3 2022 | $947,000 | -12.3% | 919,068 | -42.1% | 0.00% | 0.0% |
| Q2 2022 | $1,080,000 | +496.7% | 1,586,989 | +634.7% | 0.00% | – |
| Q1 2022 | $181,000 | -85.4% | 216,005 | -71.5% | 0.00% | -100.0% |
| Q4 2021 | $1,236,000 | -62.0% | 758,295 | -43.8% | 0.00% | -50.0% |
| Q3 2021 | $3,254,000 | -34.4% | 1,350,283 | -28.1% | 0.00% | -33.3% |
| Q2 2021 | $4,959,000 | +54.2% | 1,878,474 | +191.4% | 0.00% | +50.0% |
| Q1 2021 | $3,216,000 | +1409.9% | 644,543 | +918.3% | 0.00% | – |
| Q1 2019 | $213,000 | – | 63,299 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
| 1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
| Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
| ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
| Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
| Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
| Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |